Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety
Therapie, 67 4 (2012) 329-337
Publié en ligne : 1 novembre 2012
DOI: 10.2515/therapie/2012046